These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 27852202)

  • 1. Protein Structure Network-based Drug Design.
    Liang Z; Hu G
    Mini Rev Med Chem; 2016; 16(16):1330-1343. PubMed ID: 27852202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Design based on Protein Structure Network.
    Liang Z; Hu G
    Mini Rev Med Chem; 2016 May; ():. PubMed ID: 27215941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing Polypharmacology with Computer-Aided Drug Design and Systems Biology.
    Wathieu H; Issa NT; Byers SW; Dakshanamurthy S
    Curr Pharm Des; 2016; 22(21):3097-108. PubMed ID: 26907947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.
    Wang T; Wu MB; Zhang RH; Chen ZJ; Hua C; Lin JP; Yang LR
    Curr Top Med Chem; 2016; 16(9):901-16. PubMed ID: 26303430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative and systems pharmacology 2. In silico polypharmacology of G protein-coupled receptor ligands via network-based approaches.
    Wu Z; Lu W; Yu W; Wang T; Li W; Liu G; Zhang H; Pang X; Huang J; Liu M; Cheng F; Tang Y
    Pharmacol Res; 2018 Mar; 129():400-413. PubMed ID: 29133212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for the Rational Design of Allosteric Modulators of Class C GPCRs.
    Christopher JA; Doré AS; Tehan BG
    Curr Top Med Chem; 2017; 17(1):71-78. PubMed ID: 27448651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances on the Network Models in Target-based Drug Discovery.
    Yan W; Zhang D; Shen C; Liang Z; Hu G
    Curr Top Med Chem; 2018; 18(13):1031-1043. PubMed ID: 30027851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intra and inter-molecular communications through protein structure network.
    Vishveshwara S; Ghosh A; Hansia P
    Curr Protein Pept Sci; 2009 Apr; 10(2):146-60. PubMed ID: 19355982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in automated protein design and its future challenges.
    Setiawan D; Brender J; Zhang Y
    Expert Opin Drug Discov; 2018 Jul; 13(7):587-604. PubMed ID: 29695210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systems biology and systems chemistry: new directions for drug discovery.
    Brown JB; Okuno Y
    Chem Biol; 2012 Jan; 19(1):23-8. PubMed ID: 22284351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational chemical biology and drug design: Facilitating protein structure, function, and modulation studies.
    Zheng M; Zhao J; Cui C; Fu Z; Li X; Liu X; Ding X; Tan X; Li F; Luo X; Chen K; Jiang H
    Med Res Rev; 2018 May; 38(3):914-950. PubMed ID: 29323726
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics Analyses and Comparisons of the Protein Structure Networks Constructed by Different Methods.
    Cheng S; Fu HL; Cui DX
    Interdiscip Sci; 2016 Mar; 8(1):65-74. PubMed ID: 26297308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and computational biology of the molecular chaperone Hsp90: from understanding molecular mechanisms to computer-based inhibitor design.
    Verkhivker GM; Dixit A; Morra G; Colombo G
    Curr Top Med Chem; 2009; 9(15):1369-85. PubMed ID: 19860735
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In silico polypharmacology of natural products.
    Fang J; Liu C; Wang Q; Lin P; Cheng F
    Brief Bioinform; 2018 Nov; 19(6):1153-1171. PubMed ID: 28460068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPC Analysis of Multiple Binding Sites Communication and Allosteric Modulations in Drug Design: The HSP Case Study.
    Chiappori F; Milanesi L; Merelli I
    Curr Drug Targets; 2016; 17(14):1610-1625. PubMed ID: 26648062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based drug design to augment hit discovery.
    Kalyaanamoorthy S; Chen YP
    Drug Discov Today; 2011 Sep; 16(17-18):831-9. PubMed ID: 21810482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular modeling of vasopressin receptor and in silico screening of V1b receptor antagonists.
    Hagiwara Y; Ohno K; Kamohara M; Takasaki J; Watanabe T; Fukunishi Y; Nakamura H; Orita M
    Expert Opin Drug Discov; 2013 Aug; 8(8):951-64. PubMed ID: 23682717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural biology and drug discovery.
    Scapin G
    Curr Pharm Des; 2006; 12(17):2087-97. PubMed ID: 16796557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent Advances in Structure-Based Drug Design Targeting Class A G Protein-Coupled Receptors Utilizing Crystal Structures and Computational Simulations.
    Lee Y; Basith S; Choi S
    J Med Chem; 2018 Jan; 61(1):1-46. PubMed ID: 28657745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.